Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-2.69%
1,068.24
-29.57
-2.69%
1,097.811,087.761,087.761,067.42
SIXC
Communications
SIXC
Communications
SIXC
-0.89%
606.59
-5.44
-0.89%
612.03612.03612.03606.13
SIXE
Energy
SIXE
Energy
SIXE
+2.19%
1,247.21
+26.78
+2.19%
1,220.431,221.991,247.601,221.99
SIXI
Industrials
SIXI
Industrials
SIXI
-1.82%
1,727.58
-31.94
-1.82%
1,759.521,754.311,754.311,723.60
SIXM
Financials
SIXM
Financials
SIXM
-0.32%
629.54
-2.00
-0.32%
631.54631.27633.99628.63
SIXR
Staples
SIXR
Staples
SIXR
-0.42%
853.60
-3.56
-0.42%
857.16858.91861.71852.33
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-1.56%
212.04
-3.37
-1.56%
215.41215.41215.41211.88
SIXT
Technology
SIXT
Technology
SIXT
-1.78%
3,549.76
-64.39
-1.78%
3,614.153,556.243,598.363,516.86
SIXU
Utilities
SIXU
Utilities
SIXU
-2.40%
886.49
-21.81
-2.40%
908.30906.55906.55885.88
SIXV
Health care
SIXV
Health care
SIXV
-1.08%
1,464.34
-16.06
-1.08%
1,480.401,479.551,484.431,462.52
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.84%
2,354.25
-44.12
-1.84%
2,398.372,373.092,373.092,350.27
INBX:NASDAQ
Inhibrx Biosciences Inc
$108.64
-6.47%
(-7.52) 1D
May 15, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INBX...
Open
$118.58
High
$118.58
Low
$102.17
Mkt. cap
1.59B
Avg. vol.
569.39K
Volume
394.32K
52-wk high
$155.29
52-wk low
$12.02
EPS
-$9.04
Shares outstanding
14.61M
No. of employees
110
News stories
From sources across the web
About Inhibrx Biosciences Inc
CEO-
Employees110
Founded2024
HeadquartersLa Jolla, California, United States
SectorBiotechnology
Last report
May 22, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
-$2.15 / -$1.20
-79.17%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.30M
-
-
-
Cost of goods sold
22.27M
28.54M
25.35M
-
Cost of revenue
22.27M
28.54M
25.35M
-
Research and development expenses
-
-
-
25.22M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.42M
5.28M
5.57M
5.71M
Operating expense
6.42M
5.28M
5.57M
30.93M
Total operating expenses
28.69M
33.81M
30.92M
30.93M
Operating income
-27.39M
-33.81M
-30.92M
-30.93M
Other non operating income
-246.00K
-46.00K
-39.00K
-12.00K
EBT including unusual items
-28.65M
-35.26M
-32.83M
-33.44M
EBT excluding unusual items
-28.65M
-35.26M
-32.83M
-33.44M
Income tax expense
2.00K
-
-
-
Effective tax rate
-0.01%
-
-
-
Other operating expenses
-
-
-
-
Net income
-28.65M
-35.26M
-32.83M
-33.44M
Net profit margin
-2,204.15%
-
-
-
Earnings per share
-1.85
-2.28
-2.11
-2.15
Interest and investment income
2.12M
1.78M
1.31M
1.01M
Interest expense
-3.14M
-3.18M
-3.18M
-3.51M
Net interest expenses
-1.02M
-1.40M
-1.87M
-2.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
-26.73M
-33.23M
-30.36M
-30.39M
Gain or loss from assets sale
-
3.00K
9.00K
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more